1. Home
  2. IPHA vs MHH Comparison

IPHA vs MHH Comparison

Compare IPHA & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • MHH
  • Stock Information
  • Founded
  • IPHA 1999
  • MHH 1986
  • Country
  • IPHA France
  • MHH United States
  • Employees
  • IPHA N/A
  • MHH 1397
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • MHH Professional Services
  • Sector
  • IPHA Health Care
  • MHH Consumer Discretionary
  • Exchange
  • IPHA Nasdaq
  • MHH Nasdaq
  • Market Cap
  • IPHA 148.3M
  • MHH 167.4M
  • IPO Year
  • IPHA 2019
  • MHH N/A
  • Fundamental
  • Price
  • IPHA $1.77
  • MHH $14.30
  • Analyst Decision
  • IPHA Strong Buy
  • MHH
  • Analyst Count
  • IPHA 1
  • MHH 0
  • Target Price
  • IPHA $11.50
  • MHH N/A
  • AVG Volume (30 Days)
  • IPHA 42.3K
  • MHH 29.9K
  • Earning Date
  • IPHA 09-12-2024
  • MHH 02-05-2025
  • Dividend Yield
  • IPHA N/A
  • MHH N/A
  • EPS Growth
  • IPHA N/A
  • MHH N/A
  • EPS
  • IPHA N/A
  • MHH N/A
  • Revenue
  • IPHA $36,202,722.00
  • MHH $194,248,000.00
  • Revenue This Year
  • IPHA N/A
  • MHH $0.53
  • Revenue Next Year
  • IPHA $101.65
  • MHH $1.53
  • P/E Ratio
  • IPHA N/A
  • MHH N/A
  • Revenue Growth
  • IPHA N/A
  • MHH N/A
  • 52 Week Low
  • IPHA $1.29
  • MHH $7.15
  • 52 Week High
  • IPHA $3.51
  • MHH $16.00
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 46.55
  • MHH 49.42
  • Support Level
  • IPHA $1.65
  • MHH $13.81
  • Resistance Level
  • IPHA $1.87
  • MHH $15.40
  • Average True Range (ATR)
  • IPHA 0.12
  • MHH 0.92
  • MACD
  • IPHA -0.03
  • MHH -0.08
  • Stochastic Oscillator
  • IPHA 33.47
  • MHH 35.43

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

Share on Social Networks: